| 临床重要耐药菌感染传播防控策略专家共识 |
| |
| 引用本文： | 杨启文,吴安华,胡必杰,李六亿,刘运喜,孙自镛,吕晓菊,施毅,卓超,郑波,宗志勇,盛国平,宁永忠,张嵘,胡付品,陈中举,李福琴,姜亦虹,战榕,孙树梅,俞云松,徐英春,欧洲临床微生物和感染病学会药敏委员会华人抗菌药物敏感性试验委员会.临床重要耐药菌感染传播防控策略专家共识[J].中国感染控制杂志,2021,20(1):1-14. |
| |
| 作者姓名： | 杨启文 吴安华 胡必杰 李六亿 刘运喜 孙自镛 吕晓菊 施毅 卓超 郑波 宗志勇 盛国平 宁永忠 张嵘 胡付品 陈中举 李福琴 姜亦虹 战榕 孙树梅 俞云松 徐英春 欧洲临床微生物和感染病学会药敏委员会华人抗菌药物敏感性试验委员会 |
| |
| 作者单位： | 临床重要耐药菌感染传播防控策略专家共识 |
| |
| 基金项目： | 国家重点研发计划"生物安全关键技术研发"重点专项（2018YFC1200100、2018YFC1200105） |
| |
| 摘 要： | 耐药菌的传播严重威胁人类健康,目前耐药问题日益加剧,给医疗卫生造成极大负担。加强耐药菌感染的预防、控制和诊疗能力建设是医疗机构防控耐药菌感染传播的重要内容。本共识分析当前临床重要耐药菌的流行病学、耐药机制及实验室检测现状,并提出耐药菌感染传播防控的专家推荐意见,旨在提高防控意识,规范临床重要耐药菌感染传播防控策略,明确防控流程。
|
| 关 键 词： | 耐药菌 多重耐药菌 流行病学 耐药机制 感染防控 耐药监测 医院感染 |
| 收稿时间： | 2020/10/14 0:00:00 |
Expert consensus on strategies for the prevention and control of spread of clinically important antimicrobial-resistant organisms |
| |
| YANG Qi-wen,WU An-hu,HU Bi-jie,LI Liu-yi,LIU Yun-xi,SUN Zi-yong,LYU Xiao-ju,SHI Yi,ZHUO Chao,ZHENG Bo,ZONG Zhi-yong,SHENG Guo-ping,NING Yong-zhong,ZHANG Rong,HU Fu-pin,CHEN Zhong-ju,LI Fu-qin,JIANG Yi-hong,ZHAN Rong,SUN Shu-mei,YU Yun-song,XU Ying-chun,Chinese Commi-ttee on Antimicrobial Susceptibility Testing,European Committee on Antimicrobial Susceptibility Testing,European Society of Clinical Microbiology and Infectious Diseases.Expert consensus on strategies for the prevention and control of spread of clinically important antimicrobial-resistant organisms[J].Chinese Journal of Infection Control,2021,20(1):1-14. |
| |
| Authors: | YANG Qi-wen WU An-hu HU Bi-jie LI Liu-yi LIU Yun-xi SUN Zi-yong LYU Xiao-ju SHI Yi ZHUO Chao ZHENG Bo ZONG Zhi-yong SHENG Guo-ping NING Yong-zhong ZHANG Rong HU Fu-pin CHEN Zhong-ju LI Fu-qin JIANG Yi-hong ZHAN Rong SUN Shu-mei YU Yun-song XU Ying-chun Chinese Commi-ttee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing European Society of Clinical Microbiology and Infectious Diseases |
| |
| Institution: | 1. Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China;2. Center for Healthcare-associated Infection Control, Xiangya Hospital, Central South University, Changsha 410008, China;3. Department of Infectious Diseases, Fudan University Zhongshan Hospital, Shanghai 200032, China;4. Department of Infection Control, Peking University First Hospital, Beijing 100034, China;5. Department of Infection Control, Chinese PLA General Hospital, Beijing 100039, China;6. Department of Clinical Laboratory, Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology, Wuhan 430030, China;7. Center for Infectious Diseases, West China Hospital of Sichuan University, Chengdu 610041, China;8. Department of Respiratory Diseases, General Hospital of Eastern Theater Command, PLA, Nanjing 210002, China;9. National Key Laboratory for Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120;10. Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China;11. State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310003, China;12. Department of Clinical Laboratory, Beijing Chuiyangliu Hospital, Beijing 100022, China;13. Department of Clinical Laboratory, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China;14. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai 200040, China;15. Department of Infection Control, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China;16. Department of Infection Control, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China;17. Department of Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China;18. Department of Infection Control, Nanfang Hospital, Southern Medical University, Guang-zhou 510515, China;19. Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, China |
| |
| Abstract: | Transmission of antimicrobial-resistant organisms(AROs) is a serious threat to human health, currently, the problem of antimicrobial resistance is becoming more and more serious, causing a great burden on medical and health care. Strengthening the prevention, control, diagnosis and treatment of AROs infection is an important part of the prevention and control of AROs infection in medical institutions. This consensus analyzes the current situation of epidemiology, antimicrobial resistance mechanism and laboratory detection of clinically important AROs, and puts forward expert recommendations on the prevention and control of transmission of AROs infection, aiming to improve the awareness of prevention and control, standardize the prevention and control strategy of transmission of clinically important AROs infection, and clarify the prevention and control process. |
| |
| Keywords: | antimicrobial-resistant organism|multidrug-resistant organism|epidemiology|antimicrobial resis-tance mechanism|infection prevention and control|antimicrobial resistance surveillance|healthcare-associated infection |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《中国感染控制杂志》浏览原始摘要信息 |
| 点击此处可从《中国感染控制杂志》下载免费的PDF全文 |
|
